All case studies
Case studyASX:NUZ
How Neurizon raised $17.8m by directly engaging 20% of their shareholder base.
Dr Michael Thurn (CEO) maximised investor attention and demand throughout a capital raise.
- Industry
- Biotechnology
- 9 months
- With InvestorHub
- $17.8m
- Capital raised
- 3.9x
- More capital than target
01
Problem
Companies struggle to identify and capitalise on latent investor demand during a raise.
02
Impact
Neurizon raised $17.8m in total, with $7.8m via a heavily oversubscribed SPP (3.9x the original target) and 20% of the register participating.
“
20% of our share registry participated in the capital raise. The $17.8m we've raised gives us the funding and confidence to pursue our objectives.